• Raising the profile and impact of endovascular vascular research
• Developing the research leaders of the future
• Increasing investment in research activities and programmes of study through sustainable research funding streams.

The BSET-CLEVAR registry is a prospective, multi-centre, observational cohort study of patients treated with the GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System (EXCC Device)

The primary objective of the registry is to collect real-world clinical data and device-specific outcomes of EXCC Device in routine clinical treatment of patients with abdominal aortic aneurysm (AAA)

Further information